RxDoctor Payments Data

Gary Weinstein, MD

Psychiatry · Forest Hills, NYNPI 1184712945

Payments from drug & device makers

$1,321in general payments, 2019–2025

Across 71 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$628
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$297
  • Vanda Pharmaceuticals Inc.$96
  • Alkermes, Inc.$91
  • Johnson & Johnson$80
  • Amarin Pharma, Inc.$56
  • plus $74 from 3 others

What the payments were for

  • Food & beverage$1,321100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,321 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$137,157
Medicare patients
264
Services billed
1,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole86$128,581
NamzaricMemantine Hcl/Donepezil Hcl213$117,575
LatudaLurasidone Hcl74$96,660
Wellbutrin XlBupropion Hcl26$59,080
VraylarCariprazine Hcl39$51,024
ZyprexaOlanzapine24$13,856
TrintellixVortioxetine Hydrobromide27$13,057
Rivastigmine129$11,556
Lurasidone Hcl44$11,518
EliquisApixaban12$8,266
Dihydroergotamine Mesylate11$8,166
Seroquel XrQuetiapine Fumarate13$7,696
LinzessLinaclotide13$6,275
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$5,638
MyrbetriqMirabegron12$4,930

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieNamzaric, Vraylar, Linzess$628$174,874265 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Forest Hills

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →